These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20435434)

  • 41. PPA250 [3-(2,4-difluorophenyl)-6-[2-[4-(1H-imidazol-1-ylmethyl) phenoxy]ethoxy]-2-phenylpyridine], a novel orally effective inhibitor of the dimerization of inducible nitric-oxide synthase, exhibits an anti-inflammatory effect in animal models of chronic arthritis.
    Ohtsuka M; Konno F; Honda H; Oikawa T; Ishikawa M; Iwase N; Isomae K; Ishii F; Hemmi H; Sato S
    J Pharmacol Exp Ther; 2002 Oct; 303(1):52-7. PubMed ID: 12235232
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT).
    Konturek SJ; Konturek PC; Brzozowska I; Pawlik M; Sliwowski Z; Cześnikiewicz-Guzik M; Kwiecień S; Brzozowski T; Bubenik GA; Pawlik WW
    J Physiol Pharmacol; 2007 Sep; 58(3):381-405. PubMed ID: 17928638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Utilizing melatonin to combat bacterial infections and septic injury.
    Hu W; Deng C; Ma Z; Wang D; Fan C; Li T; Di S; Gong B; Reiter RJ; Yang Y
    Br J Pharmacol; 2017 May; 174(9):754-768. PubMed ID: 28213968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock.
    Cuzzocrea S; Mazzon E; Di Paola R; Esposito E; Macarthur H; Matuschak GM; Salvemini D
    J Pharmacol Exp Ther; 2006 Oct; 319(1):73-81. PubMed ID: 16815867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanism-oriented therapy for multiple systems organ failure.
    Sheagren JN
    Crit Care Clin; 1989 Apr; 5(2):393-409. PubMed ID: 2650824
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiinflammatory but no neuroprotective effects of melatonin under clinical treatment conditions in rabbit models of bacterial meningitis.
    Spreer A; Gerber J; Baake D; Hanssen M; Huether G; Nau R
    J Neurosci Res; 2006 Nov; 84(7):1575-9. PubMed ID: 16998917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Melatonin: pharmacological aspects and clinical trends.
    Rios ER; Venâncio ET; Rocha NF; Woods DJ; Vasconcelos S; Macedo D; Sousa FC; Fonteles MM
    Int J Neurosci; 2010 Sep; 120(9):583-90. PubMed ID: 20707632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostaglandin synthetase inhibitors in endotoxin or septic shock--a review.
    Fletcher JR
    Adv Shock Res; 1983; 10():9-14. PubMed ID: 6410700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated nucleosome levels in systemic inflammation and sepsis.
    Zeerleder S; Zwart B; Wuillemin WA; Aarden LA; Groeneveld AB; Caliezi C; van Nieuwenhuijze AE; van Mierlo GJ; Eerenberg AJ; Lämmle B; Hack CE
    Crit Care Med; 2003 Jul; 31(7):1947-51. PubMed ID: 12847387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Nitric oxide--an important mediator in sepsis?].
    Kirkebøen KA; Strand OA
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4061-5. PubMed ID: 10613098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melatonin as a therapeutic agent in experimental endotoxic shock.
    Maestroni GJ
    J Pineal Res; 1996 Mar; 20(2):84-9. PubMed ID: 8815192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of Melatonin in the Inflammatory Process and its Therapeutic Potential.
    Carrascal L; Nunez-Abades P; Ayala A; Cano M
    Curr Pharm Des; 2018; 24(14):1563-1588. PubMed ID: 29701146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Melatonin: A window into the organ-protective effects of sepsis.
    Liu R; Luo X; Li J; Lei Y; Zeng F; Huang X; Lan Y; Yang F
    Biomed Pharmacother; 2022 Oct; 154():113556. PubMed ID: 35994818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-inflammatory therapies in sepsis and septic shock.
    Freeman BD; Natanson C
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1651-63. PubMed ID: 11060768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Melatonin for the treatment of sepsis: the scientific rationale.
    Colunga Biancatelli RML; Berrill M; Mohammed YH; Marik PE
    J Thorac Dis; 2020 Feb; 12(Suppl 1):S54-S65. PubMed ID: 32148926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pineal gland hormone melatonin improves survival in a rat model of sepsis/shock induced by zymosan A.
    Reynolds FD; Dauchy R; Blask D; Dietz PA; Lynch D; Zuckerman R
    Surgery; 2003 Sep; 134(3):474-9. PubMed ID: 14555936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involvement of the nitric oxide in melatonin-mediated protection against injury.
    Fan W; He Y; Guan X; Gu W; Wu Z; Zhu X; Huang F; He H
    Life Sci; 2018 May; 200():142-147. PubMed ID: 29567076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Melatonin: new applications in clinical and veterinary medicine, plant physiology and industry.
    Reiter RJ; Coto-Montes A; Boga JA; Fuentes-Broto L; Rosales-Corral S; Tan DX
    Neuro Endocrinol Lett; 2011; 32(5):575-87. PubMed ID: 22167140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxidative stress in sepsis: Pathophysiological implications justifying antioxidant co-therapy.
    Prauchner CA
    Burns; 2017 May; 43(3):471-485. PubMed ID: 28034666
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential benefits of melatonin in organ transplantation: a review.
    Esteban-Zubero E; García-Gil FA; López-Pingarrón L; Alatorre-Jiménez MA; Iñigo-Gil P; Tan DX; García JJ; Reiter RJ
    J Endocrinol; 2016 Jun; 229(3):R129-46. PubMed ID: 27068700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.